A new class of innovative TCR

therapies to treat cancer

home-about.jpg

About us

Axis is a leading cancer immunotherapy company focused on developing T cell therapies to bring an effective immunotherapy to cancer patients around the world.

 
home-science.jpg

Science

Our TCR-T technology is at the forefront of cancer immunotherapies. Our mission is to create effective and safe T cell therapies that target a broad range of cancers.

News